Concerned about often uneven and suboptimal care of gout, despite numerous guidelines and new therapies, an international panel of rheumatologists issues new recommendations for diagnosis and management.
Data from two large prospective studies confirm earlier suggestions that gout risk is increased among patients with psoriasis and psoriatic arthritis, independent of possible contributing factors such as metabolic syndrome.
Why are gout patients seeking treatment from their healthcare providers at three times the rate they were in the later 20th century? Researchers suggest that better disease awareness and an aging population may hold the answers.
(AUDIO) African Americans are not treated as effectively for gout as Caucasians. In this recorded interview, Dr. Jasvinder Singh ponders the meaning of this disparity and gives advice about how doctors can assure the best treatment for gout in all ethnic groups.
(AUDIO) New ACR guidelines on gout advise considering a test for the HLA-B*5801 allele linked to allopurinol sensitivity in some patients. This podcast by the co-chair of the panel clarifies the details.